David Greenberg
About David Greenberg
David Greenberg serves as the Israel Chief Medical Officer at Beyond Air/Beyond Cancer, where he has worked since 2022. He holds a Doctor of Medicine degree from Ben-Gurion University of the Negev and has contributed to significant research in oncology and pediatrics.
Work at Beyond Air
David Greenberg serves as the Chief Marketing Officer (CMO) for Beyond Air and Beyond Cancer in Israel. He has held this position since 2022, contributing to the company's initiatives in both the USA and Israel. His role involves overseeing marketing strategies and promoting the company's innovative approaches to cancer treatment.
Education and Expertise
David Greenberg earned his Doctor of Medicine (MD) degree from Ben-Gurion University of the Negev. His academic focus included pediatrics and infectious diseases, equipping him with a strong foundation in medical science and patient care.
Research Contributions
David Greenberg has actively participated in significant research within the field of oncology. He contributed to a poster presentation on ultra-high concentration nitric oxide (UNO) for treating relapsed or refractory, unresectable malignancies. Additionally, he co-authored a study that explored the effects of intratumoral administration of high-concentration nitric oxide combined with anti PD-1 treatment, which resulted in higher tumor regression rates and prolonged survival in CT26 tumor-bearing mice.
Involvement in Innovative Research
David Greenberg is involved in research focusing on the impact of UNO101 on the tumor microenvironment in cases of relapsed or refractory, unresectable malignancies. His work aims to enhance understanding of treatment efficacy and improve outcomes for patients with challenging cancer diagnoses.